Analyst Ratings for ARIAD Pharmaceuticals (ARIA) [Buys]

Overall Rating: BUY Rating Trend: = Avg. $ Target: $25.06 (+28.9%)

Date	Firm	Type	Rating (Past)	PT (Past)	Start $	End $	% Chg.	Details
2/8/2013	JMP Securities	New Coverage	Market Outperform (N/A)	32.00 (N/A)	19.80	19.44	-1.82%	Details
11/9/2012	Guggenheim	New Coverage	Buy (N/A)	30.00 (N/A)	20.76	19.44	-6.36%	Details
10/26/2012	Citi	New Coverage	Buy (N/A)	31.00 (N/A)	21.97	19.44	-11.52%	Details
9/10/2012	BofA/Merrill Lynch	Upgrade	Buy (Neutral)	N/A (N/A)	22.01	19.44	-11.68%	Details
7/30/2012	William Blair	New Coverage	Outperform (N/A)	25.00 (N/A)	18.92	19.44	2.75%	Details
4/12/2012	UBS » Updated 10/2/2012	New Coverage	Buy (N/A)	29.00 (23.00)	15.14	19.44	28.4%	Details
3/15/2012	Stifel Nicolaus	New Coverage	Buy (N/A)	19.00 (N/A)	15.12	19.44	28.57%	Details
2/14/2012	RBC Capital » Updated 5/22/2013	New Coverage	Outperform (N/A)	36.00 (N/A)	15.25	19.44	27.48%	Details
1/19/2012	Maxim Group	New Coverage	Buy (N/A)	20.00 (N/A)	14.45	19.44	34.53%	Details
10/14/2011	Rodman & Renshaw	New Coverage	Market Outperform (N/A)	15.00 (N/A)	9.94	19.44	95.57%	Details
9/8/2011	BMO Capital	New Coverage	Outperform (N/A)	18.00 (N/A)	9.89	19.44	96.56%	Details
8/25/2011	Summer Street	New Coverage	Buy (N/A)	16.00 (N/A)	8.83	19.44	120.16%	Details
8/1/2011	Monness, Crespi, Hardt	New Coverage	Buy (N/A)	22.00 (N/A)	11.89	19.44	63.5%	Details
5/25/2011	Brean Capital » Updated 10/1/2012	New Coverage	Buy (N/A)	35.00 (19.00)	8.23	19.44	136.21%	Details
3/24/2011	Williams Capital	New Coverage	Outperform (N/A)	N/A (N/A)	6.35	19.44	206.14%	Details

Like ARIA Ratings? Also take a look at SNE, AAPL, MRK, GOL